Support & Awards

  • Early HORMÆ Pharma’s project was supported by Pulsalys and INSERM.
  •  HORMÆ Pharma was granted a Deep Tech Emergence fundings in February 2021 and a French Tech Seed loan in July 2021 by Banque Publique Investissement (BPI)
  • HORMÆ Pharma was laureate of the French Research Minister’s i-Lab® 2021 contest. 


Hormæ Pharma and two Inserm teams at the CIRI have engaged a collaboration in July 2021. The collaborative program was awarded a grant from the "Cancéropôle Lyon Auvergne Rhône Alpes" (CLARA) Proof of Concept 2021 call for project.

  • The VIRIMIVIRal Infection, Metabolism, and Immunity” team formerly led by V. Lotteau and since December 2022 by P.O. Vidalain is an internationally recognized team for the study of the interplays between viral infection and metabolism. 
  • The LIBLymphoma Immuno-Biology” team led by L. Genestier & E. Bachy is a leading laboratory in the study of lymphomas and is a member of  LYSARC (The Lymphoma Academic Research Organisation), a European clinical research organisation on lymphomas.